These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The ghosts of departed quantities: approaches to dealing with observations below the limit of quantitation. Senn S; Holford N; Hockey H Stat Med; 2012 Dec; 31(30):4280-95. PubMed ID: 22825800 [TBL] [Abstract][Full Text] [Related]
45. Percentile regression analysis of correlated antibody responses. Moulton LH; Holt EA; Job JS; Halsey NA Stat Med; 1995 Apr; 14(8):777-87. PubMed ID: 7644858 [TBL] [Abstract][Full Text] [Related]
46. A gamma model for extra-binomial variation in dilution assays. O'Neill TJ; O'Neill HC Biometrics; 1993 Mar; 49(1):237-42. PubMed ID: 8513105 [TBL] [Abstract][Full Text] [Related]
47. Repeated measures with zeros. Berk KN; Lachenbruch PA Stat Methods Med Res; 2002 Aug; 11(4):303-16. PubMed ID: 12197298 [TBL] [Abstract][Full Text] [Related]
48. A mixed gamma model for regression analyses of quantitative assay data. Moulton LH; Halsey NA Vaccine; 1996 Aug; 14(12):1154-8. PubMed ID: 8911013 [TBL] [Abstract][Full Text] [Related]
49. Statistical tests for latent class in censored data due to detection limit. He H; Tang W; Kelly T; Li S; He J Stat Methods Med Res; 2020 Aug; 29(8):2179-2197. PubMed ID: 31736411 [TBL] [Abstract][Full Text] [Related]
50. A mixture model for occupational exposure mean testing with a limit of detection. Taylor DJ; Kupper LL; Rappaport SM; Lyles RH Biometrics; 2001 Sep; 57(3):681-8. PubMed ID: 11550915 [TBL] [Abstract][Full Text] [Related]
51. A new statistical test for latent class in censored data due to detection limit. Zou Y; Peng Z; Cornell J; Ye P; He H Stat Med; 2021 Feb; 40(3):779-798. PubMed ID: 33159355 [TBL] [Abstract][Full Text] [Related]
52. Estimation in generalized linear models under censored covariates with an application to MIREC data. Lee WC; Sinha SK; Arbuckle TE; Fisher M Stat Med; 2018 Dec; 37(29):4539-4556. PubMed ID: 30168157 [TBL] [Abstract][Full Text] [Related]
53. Infections reveal inequality between the sexes. Reardon S Nature; 2016 Jun; 534(7608):447. PubMed ID: 27337319 [No Abstract] [Full Text] [Related]
54. Clinical cross-over trials in phase I. Senn S; Ezzet F Stat Methods Med Res; 1999 Sep; 8(3):263-78. PubMed ID: 10636338 [TBL] [Abstract][Full Text] [Related]
55. Some comments on analysis techniques for censored water quality data. Farewell VT Environ Monit Assess; 1989 Nov; 13(2-3):285-94. PubMed ID: 24243177 [TBL] [Abstract][Full Text] [Related]
56. Using orthogonal polynomial scores in summarizing and evaluating longitudinal data collected in phase I and II clinical pharmacology studies. Bradstreet TE Stat Med; 1993 Apr; 12(7):633-43. PubMed ID: 8511440 [TBL] [Abstract][Full Text] [Related]
57. The measurement and interpretation of age-specific vaccine efficacy. Farrington CP Int J Epidemiol; 1992 Oct; 21(5):1014-20. PubMed ID: 1468838 [TBL] [Abstract][Full Text] [Related]